Theratechnologies Inc. (THTX) Income Annual - Discounting Cash Flows
THTX
Theratechnologies Inc.
THTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
11-30
2023
11-30
2022
11-30
2021
11-30
2020
11-30
2019
11-30
2018
11-30
2017
11-30
2016
11-30
2015
11-30
2014
11-30
2013
11-30
2012
11-30
2011
11-30
2010
11-30
2009
11-30
2008
11-30
2007
11-30
2006
11-30
2005
11-30
2004
11-30
2003
11-30
2002
11-30
2001
11-30
2000
11-30
1999
11-30
1998
11-30
1997
11-30
1996
11-30
Report Filing 2025-07-09 2025-02-26 2023-11-30 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30 2017-11-30 2016-11-30 2015-11-30 2014-11-30 2013-11-30 2012-11-30 2011-11-30 2010-11-30 2009-11-30 2008-11-30 2007-11-30 2006-11-30 2005-11-30 2004-11-30 2003-11-30 2002-11-30 2001-11-30 2000-11-30 1999-11-30 1998-11-30 1997-11-30 1996-11-30
Revenue 84.38 85.87 81.76 80.06 69.82 66.05 63.22 44.1 33.31 27.59 22.48 5.88 7.11 13.66 14.46 31.26 16.52 2.13 3.13 1.44 14.09 2.23 3.09 5.48 2.86 0.802 1.02 0.716 0.281 0.371
Cost of Revenue 18.8 20.45 19.64 26.28 23.26 26.9 26.08 12.97 7.98 4.96 3.01 2.14 3.5 5.09 8.86 0.46 0 -0.514 -0.002 -0.204 -2.37 -0.418 -0.92 -3.09 0.152 0.076 0.204 0.195 -0.119 0.148
Gross Profit 65.58 65.42 62.13 53.78 46.56 39.15 37.14 31.13 25.33 22.64 19.47 3.73 3.62 8.57 5.6 30.8 16.52 2.64 3.13 1.65 16.46 2.65 4.01 8.57 2.71 0.727 0.815 0.521 0.4 0.223
Operating Expenses 58.46 57.24 72.76 93.69 71.8 57.11 45.65 34.69 33.95 19.71 16.37 14.97 7.84 12.74 23.77 24.26 32.35 41.59 40.65 24.3 20.75 21.91 24.22 24.26 11.51 7.15 4.82 4.3 4.83 4.23
Research & Development 14.08 16.97 30.37 36.94 28.27 18.02 10.84 7.78 9.21 5.18 3.67 4.9 6.94 6.38 10.64 13.79 21.01 28.45 31.85 18.48 11.79 14.29 18.69 15.1 8.87 4.22 3.19 2.86 2.95 2.67
Selling, General and Administrative 44.38 40.27 42.39 56.75 43.52 39.09 34.81 27.52 24.74 13.04 11.28 9.18 3.83 6.36 12.44 10.47 13.24 9.84 9.61 5.07 5.51 6.45 6.24 5.24 3.74 3.92 2.38 2.34 2.39 2
Other Operating Expenses 0 0 0 0 0 0 0 -0.609 0 1.49 1.42 0.881 -2.93 -0 0.693 0 -1.9 3.31 -0.81 0.754 3.45 1.17 -0.707 3.91 -1.1 -0.995 -0.747 -0.911 -0.514 -0.445
Operating Income 7.12 8.17 -10.63 -39.91 -25.24 -17.96 -8.51 -3.56 -8.62 2.93 3.1 -11.23 -4.22 -4.17 -18.18 6.54 -15.83 -38.95 -37.51 -22.66 -4.29 -19.26 -20.21 -15.69 -8.8 -6.42 -4.01 -3.78 -4.43 -4.01
Net Non-Operating Interest -6.55 -8.93 -10.55 -6.18 -5.47 -5.29 -3.89 -1.93 -0.834 -1.4 -1.85 -0.877 0.429 0.762 0.936 2.34 1.98 3.91 2.5 1.45 1.6 2.38 3.81 5.08 3.8 2.2 0 0 0 0
Interest Income 0.786 1.49 0 0.316 0.195 0.31 1.1 0.596 0.262 0.077 0.031 0.173 0.429 0.762 1.55 2.34 2.01 3.91 2.5 1.45 1.6 2.38 3.81 5.08 3.8 2.2 0 0 0 0
Interest Expense 7.33 10.42 10.55 6.5 5.66 5.6 4.99 2.53 1.1 1.47 1.88 1.05 0 0 0.616 0 0.025 0 0 0 0 0 0 0 0 0 0 0 0 0
Equity & Other Income/(Expense) -7.4 -5.54 -2.36 -0.705 -0.957 0.6 -0.09 -0.477 -4.88 -0.754 0.349 2.94 -0.001 -10.62 0 0 -0.478 -4.37 -2.55 21.2 -9.6 -3.89 -11.27 1.63 21.57 6.57 4.01 0.456 0.422 0.371
Income Before Tax -6.83 -6.3 -23.54 -46.79 -31.66 -22.65 -12.5 -5.97 -14.34 0.781 1.6 -9.18 -3.79 -14.03 -17.24 8.87 -14.33 -39.42 -37.57 0 -12.28 -20.77 -27.67 -8.98 16.56 2.34 0 -3.32 -4.01 -3.64
Income Tax Expense 2.33 2 0.421 0.443 0.063 0.016 0 -1.27 0 0.476 0.426 0.027 0.024 0.005 -0.07 0.112 0 -0.465 -0.057 0 -7.99 -1.51 -2.43 0.183 -25.78 -10.19 -0.679 0 0 -0.223
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.093 0.465 0.057 22.66 7.99 -0.045 0 0 25.36 8.76 4.01 0 0 0.074
Net Income -9.16 -8.31 -23.96 -47.24 -31.73 -22.67 -12.5 -4.7 -14.34 0.305 1.17 -9.2 -3.82 -14.03 -17.17 8.76 -14.24 -39.42 -37.57 -22.66 -12.28 -19.22 -25.25 -9.16 16.98 3.77 -3.33 -3.32 -4.01 -3.49
Depreciation and Amortization 1.86 2.76 3.31 12.47 8.75 8.52 7.5 4.23 1.55 1.57 1.43 0.997 0.114 0.568 0.322 0.457 0.579 4.85 1.11 0.915 1.32 1.1 2.53 1.44 0.627 0.3 0.204 0.065 0.141 0.074
EBITDA 8.98 10.94 -7.31 -27.44 -16.49 -9.44 -1.02 0.669 -7.08 4.5 4.53 -10.24 -4.11 -3.6 -17.85 6.99 -15.25 -34.1 -36.4 -21.74 -2.97 -18.16 -17.68 -14.25 -8.18 -6.12 -3.8 -3.71 -4.29 -3.93
Earnings Per Share (EPS) -0.178 -0.17 -0.33 -0.5 -0.34 -0.29 -0.23 -0.06 -0.2 0.007 0.022 -0.15 -0.063 -0.23 -0.28 0.15 -0.24 -0.69 -0.71 -0.53 -0.34 -0.56 -0.82 -0.3 0.62 0.16 -0.16 -0.18 -0.24 -0.24
Diluted Earnings Per Share -0.185 -0.17 -0.33 -0.5 -0.34 -0.29 -0.23 -0.06 -0.2 0.007 0.015 -0.15 -0.063 -0.23 -0.28 0.15 -0.24 -0.69 -0.71 -0.53 -0.34 -0.54 -0.82 -0.3 0.6 0.16 -0.16 -0.18 -0.24 -0.24
Weighted Average Shares Outstanding 49.36 49.36 73.08 95.25 92.35 76.99 76.93 75.94 73.47 65.81 62.49 61.01 61.01 60.98 60.73 60.48 60.31 57.42 52.58 43.1 35.86 34.57 30.92 30.5 27.57 24.62 20.42 18.21 16.76 14.69
Diluted Weighted Average Shares Outstanding 49.36 49.36 73.08 95.25 92.35 76.99 76.93 75.94 73.47 66.6 63.17 61.01 61.01 60.98 60.73 61.32 60.31 57.42 52.58 43.1 35.86 35.48 30.92 30.5 28.37 26.9 20.42 18.21 16.76 14.69
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program